Genetic editing holds promise to treat incurable diseases, but the most popular method—CRISPR—sometimes does more harm than ...

A research team led by scientists from the Helmholtz Institute for RNA-based Infection Research (HIRI) has introduced a new ...

In the latest trading session, CRISPR Therapeutics AG (CRSP) closed at $59.07, marking a -3.46% move from the previous day.

Tulane University researchers have developed an enhanced CRISPR-based tuberculosis test that works with a simple tongue swab, ...

The study, worked to address that gap by refining a previously developed CRISPR-based assay to better detect TB in samples ...

Diagnosing tuberculosis (TB) could soon become significantly easier and more accessible, thanks to a new tongue swab test ...

Genetic editing holds promise to treat incurable diseases, but the most popular method — CRISPR — sometimes does more harm than good. A new study from ...

The potential breakthrough using an enhanced CRISPR-based technology could allow easier, community-based screenings for the world’s deadliest infectious disease, said researchers from Tulane ...

Scientists from the Helmholtz Institute for RNA-based Infection Research and collaborating institutions have developed a ...

Targeted editing of genetic information has advanced at an extraordinary pace in recent years. Tools such as the CRISPR-Cas9 "gene scissors" and base ...

Forget the glorious successes of past breakthroughs—the real justification for research investment is what we get for our ...